Difficulty: Medium
Average Score: 66%
Practice
We prescribe a beta-adrenergic blocker for a patient with chronic-stable ('effortinduced') angina, and the incidence and severity of angina attacks are reduced. Which of the following best explains the pharmacologic action by which the beta blocker does this?
Correct answer
A
Rationale
Rationale:
The correct answer is A) Decreases myocardial oxygen demand.
Beta-adrenergic blockers work by blocking the beta receptors in the heart, leading to decreased heart rate and contractility, subsequently reducing myocardial oxygen demand. This reduction in oxygen demand helps in managing chronic-stable angina by decreasing the workload on the heart muscle, hence reducing the frequency and severity of angina attacks.
Option B) Slows AV nodal conduction velocity, is incorrect because while beta blockers can slow AV nodal conduction, this mechanism is more relevant in the treatment of arrhythmias rather than angina.
Option C) Exerts anti-platelet/anti-thrombotic effects, is incorrect as this mechanism is not primarily how beta blockers alleviate angina symptoms. Antiplatelet effects are more associated with medications like aspirin.
Option D) Reduces total peripheral resistance, is incorrect as beta blockers primarily target the heart's adrenergic receptors to decrease oxygen demand rather than directly affecting peripheral resistance.
In an educational context, understanding the pharmacologic actions of cardiovascular drugs is crucial for healthcare professionals to make informed decisions in managing patients with cardiovascular conditions. Knowing how each class of drugs works helps in tailoring treatment plans to individual patient needs and optimizing therapeutic outcomes.
The correct answer is A) Decreases myocardial oxygen demand.
Beta-adrenergic blockers work by blocking the beta receptors in the heart, leading to decreased heart rate and contractility, subsequently reducing myocardial oxygen demand. This reduction in oxygen demand helps in managing chronic-stable angina by decreasing the workload on the heart muscle, hence reducing the frequency and severity of angina attacks.
Option B) Slows AV nodal conduction velocity, is incorrect because while beta blockers can slow AV nodal conduction, this mechanism is more relevant in the treatment of arrhythmias rather than angina.
Option C) Exerts anti-platelet/anti-thrombotic effects, is incorrect as this mechanism is not primarily how beta blockers alleviate angina symptoms. Antiplatelet effects are more associated with medications like aspirin.
Option D) Reduces total peripheral resistance, is incorrect as beta blockers primarily target the heart's adrenergic receptors to decrease oxygen demand rather than directly affecting peripheral resistance.
In an educational context, understanding the pharmacologic actions of cardiovascular drugs is crucial for healthcare professionals to make informed decisions in managing patients with cardiovascular conditions. Knowing how each class of drugs works helps in tailoring treatment plans to individual patient needs and optimizing therapeutic outcomes.